ORIC PHARMACEUTICALS

ORIC Pharmaceuticals to Host ASH Conference Call with Key Opinion Leader to Discuss Potential of ORIC-533 in Multiple Myeloma

09 12 2021 16:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

11 11 2021 16:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update

08 11 2021 16:05:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting

04 11 2021 09:00:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC

07 10 2021 08:55:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Multiple Data Presentations at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

30 9 2021 16:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Update on ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor

21 9 2021 06:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 9 2021 08:00:02 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors

16 8 2021 16:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update

10 8 2021 16:05:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces FDA Clearance of IND Application for ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor

28 6 2021 08:00:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel

02 6 2021 16:55:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference

26 5 2021 16:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Host Conference Call with KOL to Review Initial Data Being Presented at ASCO from Phase 1b Study of ORIC-101 in Combination with Nab-paclitaxel

25 5 2021 08:00:03 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update

06 5 2021 16:05:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Data from Ongoing Phase 1b Study of ORIC-101 in Combination with Nab-paclitaxel at the 2021 ASCO Annual Meeting

28 4 2021 16:05:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Posters on Four Programs at the 2021 American Association for Cancer Research (AACR) Annual Meeting

12 4 2021 06:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update

23 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Posters on Four Programs at the 2021 American Association for Cancer Research (AACR) Annual Meeting

10 3 2021 16:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

02 3 2021 06:30:00 提供 Nasdaq GlobeNewswire